Carmichael Hill & Associates, Inc. Seelos Therapeutics, Inc. Call Options Transaction History
Carmichael Hill & Associates, Inc.
- $279 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SEEL
# of Institutions
1Shares Held
40.5KCall Options Held
0Put Options Held
0About SEELOS THERAPEUTICS, INC.
- Ticker SEEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 106,691,000
- Market Cap $117M
- Description
- Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...